Link to this page
Medical Subject Headings
Last uploaded:
August 28, 2024
Jump to:
Preferred Name | ezogabine | |
Synonyms |
D-20443 D-23129 D 20443 D 23129 retigabine Potiga ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester |
|
ID |
http://purl.bioontology.org/ontology/MESH/C101866 |
|
altLabel |
D-20443 D-23129 D 20443 D 23129 retigabine Potiga ethyl N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamate hydrochloride N-(2-amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester
|
|
cui |
C0384053 C0530684 C0384054 C0530683 C3160375
|
|
HM |
D002219 D010655
|
|
Inverse of RB |
12G01I6BBU 0
|
|
isa | ||
LT |
TRD
|
|
Mapped to | ||
MDA |
19961122
|
|
MeSH Frequency |
357
|
|
MMR |
20130430
|
|
notation |
C101866
|
|
PA |
D000927 D049990
|
|
prefLabel |
ezogabine
|
|
RR |
150812-12-7 (ezogabine)
|
|
SC |
1
|
|
Scope Statement |
structure in first source
|
|
SRC |
Eur J Pharmacol 1996 May 15;303(3):163-9
|
|
TERMUI |
T843381 T782145 T296907 T296906 T296910 T296905 T296911 T296909 T296908
|
|
TH |
NLM (1996) FDA SRS (2013) USAN (19XX) INN (19XX) NLM (2013) NLM (2011)
|
|
tui |
T109 T121
|
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping